MerTK/Tyro3 Polyclonal Antibody

Rabbit Anti-MerTK/Tyro3 Polyclonal Antibody

Product Specifications

Background

MERTK is a member of the MER/AXL/TYRO3 receptor kinase family and encodes a transmembrane protein with two fibronectin type-III domains, two Ig-like C3-type (immunoglobulin-like) domains, and one tyrosine kinase domain. Mutations in this gene have been as

CAS Number

9007-83-4

Product Name Alternative

MERTK; MER; Tyrosine-protein kinase Mer; Proto-oncogene c-Mer; Receptor tyrosine kinase MerTK; TYRO3; BYK; DTK; RSE; SKY; Tyrosine-protein kinase receptor TYRO3; Tyrosine-protein kinase DTK; Tyrosine-protein kinase RSE; Tyrosine-protein kin

Gene ID

10461/7301

Accession Number

Q12866/Q06418

Reactivity

Human, Mouse, Rat

Immunogen

Synthesized peptide derived from human MerTK/Tyro3 around the non-phosphorylation site of Y749/681

Clonality

Polyclonal

Tag

Tyrosine-protein kinase Mer

Applications

WB, IHC, IF, ELISA

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Molecular Weight

97kD

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

MerTK/Tyro3 Polyclonal Antibody detects endogenous levels of MerTK/Tyro3 protein.

Observed Molecular Weight

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000; IHC 1:100-1:300; ELISA 1:20000; IF 1:50-200